Sign up
Quantellect · Congress · Trade Detail
NYSE: ABTAbbott Laboratories
RepublicanSenate

Markwayne Mullin sold Abbott Laboratories (NYSE: ABT)

Markwayne Mullin (R-OK), a U.S. Senator, has disclosed 4 trades in Abbott Laboratories (ABT) since 2023, 2 purchases and 2 sales, worth an estimated $81K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Markwayne Mullin sold $15,001 - $50,000 of Abbott Laboratories (NYSE: ABT) on December 11, 2024. Since that trade, ABT is down -2.49% against the S&P 500 up +22.24%, an outperformance of -24.73%.

Across these filings, Markwayne Mullin has been a balanced trader of ABT (a buy-to-sell ratio of 1.00). The most recent disclosed ABT transaction shown was dated January 8, 2025. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

ABT trades
4
Disclosed Vol
$81K
Buys
2
50%
Sells
2
50%
Buy / Sell
1.00
ratio
First → Last
2023–2025

Markwayne Mullin's ABT trades vs the price

ABT is down -2.49% since Markwayne Mullin sold on December 11, 2024, versus +22.24% for the S&P 500.

Performance since this trade

Price change since trade
-2.49%
S&P 500 change since trade
+22.24%
Outperformance vs S&P 500
-24.73%

All Markwayne Mullin ABT trades

TradedTypeSizeReturnEst. profit
January 8, 2025SELL$110.86-2.58%
December 11, 2024SELL$110.76-2.49%
October 3, 2023BUY$90.63+19.17%+$1K
September 13, 2023BUY$97.16+11.16%+$2K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Markwayne Mullin & ABT trading FAQ

Is it legal for Markwayne Mullin to trade Abbott Laboratories (ABT) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Abbott Laboratories (ABT), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Markwayne Mullin sell ABT?

Markwayne Mullin disclosed a sale of $15,001 - $50,000 of Abbott Laboratories (ABT) on December 11, 2024, according to public STOCK Act filings.

How has ABT performed since Markwayne Mullin's trade?

Since Markwayne Mullin sold ABT on December 11, 2024, the stock is down -2.49%, versus +22.24% for the S&P 500 over the same period, an outperformance of -24.73%.

How many times has Markwayne Mullin traded ABT?

Markwayne Mullin has disclosed 4 ABT trades since 2023 (2 purchases and 2 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional ABT trades?

Quantellect tracks every disclosed congressional trade in Abbott Laboratories (ABT) on the Abbott Laboratories congressional trading page, which aggregates filings across all members of Congress.

Markwayne Mullin's ABT tradesAll congressional filings for Abbott LaboratoriesMarkwayne Mullin's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.